Freeman Thomas B, Campbell James N, Long Donlin M
Department of Neurosurgery, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, Md. 21205 U.S.A.
Pain. 1983 Oct;17(2):189-195. doi: 10.1016/0304-3959(83)90142-2.
We wished to determine if pain relief that resulted from transcutaneous (TNS) or spinal cord electrical stimulation in patients with chronic pain was due to activation of an endogenous opiate-related pain control system. Naloxone (0.4-10 mg) or saline was injected in double-blind fashion intravenously into opiate-naive subjects with chronic pain who achieved 30% or greater pain relief with spinal cord stimulation (4 patients) or TNS (9 patients). Subjects rated their pain during stimulation and 2, 5, 10 and 15 min after the injection. Two days or more later the procedure was repeated using the alternate agent (naloxone or saline). Naloxone did not decrease the pain relief induced by stimulation, and therefore the effects of stimulation are probably not mediated by the endogenous opiates.
我们希望确定慢性疼痛患者经皮(经皮神经电刺激)或脊髓电刺激所产生的疼痛缓解是否归因于内源性阿片类相关疼痛控制系统的激活。将纳洛酮(0.4 - 10毫克)或生理盐水以双盲方式静脉注射到未使用过阿片类药物的慢性疼痛受试者体内,这些受试者通过脊髓刺激(4例患者)或经皮神经电刺激(9例患者)实现了30%或更大程度的疼痛缓解。受试者在刺激期间以及注射后2、5、10和15分钟对疼痛进行评分。两天或更长时间后,使用替代药物(纳洛酮或生理盐水)重复该过程。纳洛酮并未降低刺激所诱导的疼痛缓解,因此刺激的效果可能不是由内源性阿片类物质介导的。